Logo of the Belgian government
 
R285

Bevacizumab in the treatment of ovarian cancer

KCE Reports 285

Reference KCE Reports 285
Type Health Technology Assessment (HTA)
Authors Neyt Mattias, Devriese Stephan, Camberlin Cécile, Vlayen Joan
Report's Language The report is available in English. The synthesis is available in English. The supplement is available in English.
Keywords Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Ovarian Neoplasms
published on 09-05-2017